BVF INC/IL
CIK
1056807
Location
San Francisco, CA
Portfolio Value
Mid
$3,213,013,806
Diversification
Diversified
Filing Date
Global Rank
#873
/ 8,603
▲ 68
· as of Mar 2026
Top Industry
Biotechnology
97.3%
3Y Alpha vs SPY
+4.8%
Period ended 3 months ago
Filed May 15, 2026 · 55d
25 quarters · since Mar 2020
Clone Performance
Jul 2023–Jul 2026 · vs SPYHypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.
Cloned portfolio
+96.9%
SPY
+76.5%
Annualised alpha
+4.5%
Max drawdown
−43.9%
Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.
Portfolio Concentration
40 positions · as of Mar 31, 2026 · Δ vs Dec 31, 2025Top Position
14.3%
−0.1 pts
Top 5
43.1%
−1.5 pts
Top 10
60.8%
−1.8 pts
HHI
564
Diversified−18
Portfolio Trend
25 quarters · across all stocks
Sector Breakdown
As of Mar 31, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 100.0% | $3,213,013,806 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased
10 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| NKTR | Nektar Therapeutics | +1,000,000 | 2,559,595 | $184,162,860 | |
| GLUE | Monte Rosa Therapeutics, Inc. | +625,000 | 4,460,886 | $73,381,574 | |
| IRON | Disc Medicine, Inc. | +622,312 | 1,272,312 | $81,351,629 | |
| FHTX | Foghorn Therapeutics Inc. | +540,000 | 5,842,000 | $27,924,760 | |
| TCRX | TScan Therapeutics, Inc. | +338,216 | 5,564,290 | $5,619,932 | |
| IMA | ImageneBio, Inc. | +307,900 | 1,110,002 | $5,550,010 | |
| STOK | Stoke Therapeutics, Inc. | +281,883 | 2,547,557 | $82,948,455 | |
| AVTX | Avalo Therapeutics, Inc. | +277,588 | 1,632,845 | $24,378,375 | |
| MIRM | Mirum Pharmaceuticals, Inc. | +89,437 | 1,584,727 | $146,397,080 | |
| PVLA | Palvella Therapeutics, Inc. | +81,980 | 960,989 | $119,787,278 | |
| No positions match the current search. | |||||
Trimmed
Positions the filer reduced
11 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| MLTX | MoonLake Immunotherapeutics | −3,750,000 | 16,001,284 | $298,263,933 | |
| FDMT | 4D Molecular Therapeutics, Inc. | −1,750,000 | 2,879,289 | $26,806,180 | |
| RVMD | Revolution Medicines, Inc. | −500,000 | 2,856,782 | $277,822,049 | |
| ANNX | Annexon, Inc. | −429,907 | 8,698,173 | $48,187,878 | |
| SEPN | Septerna, Inc. | −367,533 | 1,353,249 | $32,518,573 | |
| ZYME | Zymeworks Inc. | −204,499 | 3,734,142 | $93,502,915 | |
| IMCR | Immunocore Holdings plc | −194,512 | 1,294,463 | $39,028,059 | |
| GHRS | GH Research PLC | −177,554 | 8,650,158 | $121,621,221 | |
| KURA | Kura Oncology, Inc. | −171,393 | 8,445,769 | $68,664,101 | |
| TYRA | Tyra Biosciences, Inc. | −151,469 | 1,976,196 | $75,688,306 | |
| GPCR | Structure Therapeutics Inc. | −19,664 | 3,459,358 | $166,741,055 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter
4 positions
40 positions ·
$3,213,013,806 total
· as of Mar 31, 2026
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| KYMR |
Kymera Therapeutics, Inc.
Healthcare
|
Held | 5,502,710 | $458,320,715 | 14.26% | |
| MLTX |
MoonLake Immunotherapeutics
Healthcare
|
Reduced | 16,001,284 | $298,263,933 | 9.28% | |
| RVMD |
Revolution Medicines, Inc.
Healthcare
|
Reduced | 2,856,782 | $277,822,049 | 8.65% | |
| NKTR |
Nektar Therapeutics
Healthcare
|
Added | 2,559,595 | $184,162,860 | 5.73% | |
| GPCR |
Structure Therapeutics Inc.
Healthcare
|
Reduced | 3,459,358 | $166,741,055 | 5.19% | |
| MIRM |
Mirum Pharmaceuticals, Inc.
Healthcare
|
Added | 1,584,727 | $146,397,080 | 4.56% | |
| GHRS |
GH Research PLC
Healthcare
|
Reduced | 8,650,158 | $121,621,221 | 3.79% | |
| PVLA |
Palvella Therapeutics, Inc.
Healthcare
|
Added | 960,989 | $119,787,278 | 3.73% | |
| ZYME |
Zymeworks Inc.
Healthcare
|
Reduced | 3,734,142 | $93,502,915 | 2.91% | |
| XNCR |
Xencor Inc
Healthcare
|
Held | 7,133,720 | $86,032,663 | 2.68% | |
| IMUX |
Immunic, Inc.
Healthcare
|
Held | 7,652,972 | $84,947,989 | 2.64% | |
| STOK |
Stoke Therapeutics, Inc.
Healthcare
|
Added | 2,547,557 | $82,948,455 | 2.58% | |
| CGEM |
Cullinan Therapeutics, Inc.
Healthcare
|
Held | 5,750,683 | $81,717,205 | 2.54% | |
| IRON |
Disc Medicine, Inc.
Healthcare
|
Added | 1,272,312 | $81,351,629 | 2.53% | |
| XOMA |
XOMA Royalty Corp
Healthcare
|
Held | 2,590,303 | $81,257,805 | 2.53% | |
| OLMA |
Olema Pharmaceuticals, Inc.
Healthcare
|
Held | 5,295,893 | $78,961,764 | 2.46% | |
| TYRA |
Tyra Biosciences, Inc.
Healthcare
|
Reduced | 1,976,196 | $75,688,306 | 2.36% | |
| GLUE |
Monte Rosa Therapeutics, Inc.
Healthcare
|
Added | 4,460,886 | $73,381,574 | 2.28% | |
| ALKS |
Alkermes plc.
Healthcare
|
NEW | 2,000,000 | $70,720,000 | 2.20% | |
| KURA |
Kura Oncology, Inc.
Healthcare
|
Reduced | 8,445,769 | $68,664,101 | 2.14% | |
| ACIU |
AC Immune SA
Healthcare
|
Held | 19,822,436 | $54,511,699 | 1.70% | |
| CBIO |
Crescent Biopharma, Inc.
Healthcare
|
Held | 2,748,763 | $50,494,776 | 1.57% | |
| ANNX |
Annexon, Inc.
Healthcare
|
Reduced | 8,698,173 | $48,187,878 | 1.50% | |
| CMPX |
Compass Therapeutics, Inc.
Healthcare
|
Held | 7,764,842 | $41,076,014 | 1.28% | |
| IMCR |
Immunocore Holdings plc
Healthcare
|
Reduced | 1,294,463 | $39,028,059 | 1.21% | |
| SEPN |
Septerna, Inc.
Healthcare
|
Reduced | 1,353,249 | $32,518,573 | 1.01% | |
| STRO |
Sutro Biopharma, Inc.
Healthcare
|
NEW | 1,251,788 | $31,182,039 | 0.97% | |
| FHTX |
Foghorn Therapeutics Inc.
Healthcare
|
Added | 5,842,000 | $27,924,760 | 0.87% | |
| FDMT |
4D Molecular Therapeutics, Inc.
Healthcare
|
Reduced | 2,879,289 | $26,806,180 | 0.83% | |
| IVVD |
Invivyd, Inc.
Healthcare
|
Held | 19,525,000 | $25,382,500 | 0.79% | |
| AVTX |
Avalo Therapeutics, Inc.
Healthcare
|
Added | 1,632,845 | $24,378,375 | 0.76% | |
| ELDN |
Eledon Pharmaceuticals, Inc.
Healthcare
|
Held | 6,293,282 | $19,383,308 | 0.60% | |
| AVR |
Anteris Technologies Global Corp.
Healthcare
|
NEW | 3,000,000 | $16,650,000 | 0.52% | |
| XFOR |
X4 Pharmaceuticals, Inc
Healthcare
|
Held | 2,233,742 | $9,225,354 | 0.29% | |
| OKUR |
OnKure Therapeutics, Inc.
Healthcare
|
NEW | 1,978,972 | $8,192,944 | 0.25% | |
| TCRX |
TScan Therapeutics, Inc.
Healthcare
|
Added | 5,564,290 | $5,619,932 | 0.17% | |
| IMA |
ImageneBio, Inc.
Healthcare
|
Added | 1,110,002 | $5,550,010 | 0.17% | |
| TENX |
Tenax Therapeutics, Inc.
Healthcare
|
Held | 339,549 | $5,429,388 | 0.17% | |
| MOLN |
Molecular Partners AG
Healthcare
|
Held | 1,353,968 | $5,373,898 | 0.17% | |
| IVA |
Inventiva S.A.
Healthcare
|
Held | 686,040 | $3,807,522 | 0.12% |